Alx Oncology Holdings (ALXO) Tax Rate (2019 - 2020)
Alx Oncology Holdings (ALXO) posted Tax Rate of 0.98% for Q4 2020, down 183.77% sequentially from 0.34% in Q3 2020, and down 105.0% YoY from 19.58% in Q1 2020.
Powered by 
Analysis
Alx Oncology Holdings (ALXO) Tax Rate (2019 - 2020) Analysis & Trends
Alx Oncology Holdings has reported Tax Rate for 2 years, with the latest figure at 0.98% in Q4 2020.
- Quarterly Tax Rate fell 105.0% year-over-year to 0.98% in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 0.53% (changed N/A YoY) and the FY2024 annual result came in at 21.0%, changed N/A from the prior year.
- Tax Rate slipped to 0.98% in Q4 2020 per ALXO's latest filing, from 0.34% in the prior quarter.
- Over five years, Tax Rate peaked at 0.07% in Q4 2019 and troughed at 0.98% in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -16.71% |
| 10 | Alx Oncology Holdings | 273.99 Mn | 273.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 51.71% |
| Sep 30, 2020 | -0.34% |
| Jun 30, 2020 | -0.18% |
| Mar 31, 2020 | -0.07% |
| Dec 31, 2019 | 47.37% |
| Sep 30, 2019 | -0.26% |
| Jun 30, 2019 | -0.19% |